VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
WSMDX
Price
$31.27
Change
+$0.11 (+0.35%)
Updated
Jun 22 closing price
Net Assets
1.31B
Interact to see
Advertisement

VMGMX vs WSMDX

VMGMX vs WSMDX Comparison Chart in %
View a ticker or compare two or three
VS
VMGMX vs. WSMDX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VMGMX is a StrongBuy and WSMDX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. WSMDX (1.31B). VMGMX pays higher dividends than WSMDX: VMGMX (0.62) vs WSMDX (0.00). VMGMX was incepted earlier than WSMDX: VMGMX (15 years) vs WSMDX (23 years). WSMDX (1.12) is less costly to investors than VMGMX (0.07). WSMDX is a more actively managed with annual turnover of: 57.00 vs. VMGMX (17.00). VMGMX has a lower initial minimum investment than WSMDX: VMGMX (3000) vs WSMDX (500000). WSMDX annual gain was more profitable for investors over the last year : 22.92 vs. VMGMX (12.44). VMGMX return over 5 years is better than : 31.82 vs. WSMDX (-17.76).
VMGMXWSMDXVMGMX / WSMDX
Total Expense Ratio0.070.997%
Annual Report Gross Expense Ratio0.071.126%
Fund Existence15 years23 years-
Gain YTD9.69413.59871%
Front LoadN/AN/A-
Min. Initial Investment30005000001%
Min. Initial Investment IRAN/AN/A-
Net Assets33.8B1.31B2,588%
Annual Yield % from dividends0.620.00-
Returns for 1 year12.4422.9254%
Returns for 3 years55.1711.72471%
Returns for 5 years31.82-17.76-179%
Returns for 10 years212.4063.83333%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX22.47N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
MRICX26.84N/A
N/A
MFS Research International C
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ALVDX11.11N/A
N/A
American Century Focused Lg Cap Val R6
BRUMX18.25N/A
N/A
MFS Blended Research Value Equity R4